For end-stage heart failure, a transplant replaces a failing heart with a donor organ. China's transplant centres concentrated in a small number of licensed, high-volume institutions perform large annual volumes with published 1-year survival consistently above 90% — among the best in the world — and at costs dramatically below Western self-pay rates.
| Option | Best suited for | What it means in practice |
|---|---|---|
| Orthotopic heart transplantation | The definitive therapy | Published Chinese 1-year survival above 90% at major licensed centres. |
| VAD / artificial-heart bridge | Transplant candidates too sick to wait | Domestic Chinese VAD devices have made bridging affordable — an option that barely exists in most of Asia. |
| Optimised medical therapy + resynchronisation | Patients who can improve without transplant | Honest listing evaluation includes maximising what medicine can still do. |
| Typical China cost (reference only) | US$90,000–140,000 all-in (surgery + first-year base immunosuppression) |
|---|---|
| Typical in-hospital stay | ICU 5–10 days, ward 2–3 weeks; rehabilitation for 4–8 weeks before flying |
| Return-to-travel timeline | Lifelong immunosuppression and monitoring; endomyocardial biopsies per protocol |
Costs are indicative ranges for international self-pay patients at major Chinese hospitals; final quotes depend on the hospital, implant/medication choice and case complexity. WellVoyage locks a written all-in quote before you commit.
Years on a transplant waitlist with a LVAD conversation looming. He listed in China, was transplanted within weeks of evaluation, and returned home with complete operative records his US cardiologist now follows.
A previous bypass had exhausted its benefit. Transplantation in Beijing; the immunosuppression protocol was handed over to his Milan team at discharge, who continue it unchanged.
A heart that never recovered after her daughter's birth. Transplanted in China when her ejection fraction hit 12%; her daughter is now six, and her heart is borrowed and perfect.
Multiple infarcts had hollowed his heart. Transplant evaluation in China moved from referral to surgery in under two months; he manages his follow-up locally with shared records.
A rare, ferocious inflammation burned through his myocardium in weeks. Bridged with mechanical support, then transplanted in Shanghai during the same admission; he went home with a new heart and an old life back.
A young father with a terminal heart and no local programme. China's organ-donation system matched him in weeks; he was back at work in Ho Chi Minh City at month six.
Defibrillator shocks and hospital admissions every few months. Transplant in Guangzhou, then structured follow-up shared between the Chinese team and her Kuala Lumpur cardiologist; her admissions are now annual check-ups, not emergencies.
Donation and allocation run through China's national system (COTRS), with voluntary non-directed donation after death. Transplants for international patients are performed only at officially licensed centres; WellVoyage works exclusively within that licensed framework and documents the full chain.
Yes, and that is the plan from day one: Chinese centres prepare a full English discharge pack — operative notes, immunosuppression levels, biopsy schedule — that your home transplant or heart-failure team continues against.
WellVoyage translates your records, obtains independent specialist opinions, and locks a transparent written quote — before you book a flight.
Start with a Free Case Review →